Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2017 Nov 1;21(11):34–41. doi: 10.5588/ijtld.17.0062

Table 1.

Characteristics of TB-HIV co-infected measurement cohort participants enrolled in the START study*

Demographic variables (n = 371)
n (%)
Age, years, median [IQR] 35 [30–44]
Female 160 (43.1)
Marital status
 Married/cohabiting 202 (54.4)
 Divorced/widowed 98 (26.4)
 Never married/cohabited 71 (19.1)
 Head of household (sole/shared) 168 (46.0)
Education
 None 29 (7.8)
 Primary 228 (61.5)
 Secondary or higher 114 (30.7)
Home amenities
 Improved drinking water 314 (84.6)
 Any electricity 178 (48.0)
  Grid electricity 108 (29.6)
  Solar electricity 51 (13.7)
  Battery/generator 38 (10.2)
Clinical variables
 Time since HIV diagnosis, days, median [IQR] 33 [20–83]
 CD4 cell count at ART initiation, /μl, median [IQR] 151 [59–307]
CIP study arm 191 (51.5)
*

Column numbers may not sum to totals due to missing data. Percentages are provided among non-missing data; missing data: age (n = 1); head of household (n = 6); time since HIV diagnosis (n = 23); CD4 count (n = 159).

TB=tuberculosis; HIV=human immunodeficiency virus; START=Start TB patients on ARTand Retain on Treatment; IQR = interquartile range; ART =antiretroviral therapy; CIP = combination intervention package.